Tradition Wealth Management, LLC Biogen Inc. Transaction History

Tradition Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $222 - $267	1 Added 1.27%	80 $21,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $506 - $571	-2 Reduced 2.47%	79 $20,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $275 - $318	1 Added 1.25%	81 $23,000
Q4 2022 Feb 03, 2023	BUY	$252.44 - $306.72 $252 - $306	1 Added 1.27%	80 $22,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $194 - $268	1 Added 1.28%	79 $21,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $18,428 - $27,739	78 New	78 $19,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Tradition Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tradition Wealth Management, LLC with notifications on news.